Temasek, Taikang lead $60m Series C2 round for Chinese speech therapy firm OST

Temasek, Taikang lead $60m Series C2 round for Chinese speech therapy firm OST

Singapore’s Temasek Holdings and Beijing-based Taikang Asset Management have co-led a $60-million Series C2 round for Orient Speech Therapy (OST), a Chinese firm that provides speech and autism therapy for kids.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter